These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Kebabian JW; Britton DR; DeNinno MP; Perner R; Smith L; Jenner P; Schoenleber R; Williams M Eur J Pharmacol; 1992 Dec; 229(2-3):203-9. PubMed ID: 1362704 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257 [TBL] [Abstract][Full Text] [Related]
4. Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. Gong L; Kostrzewa RM; Li C J Neurochem; 1994 Oct; 63(4):1282-90. PubMed ID: 7931280 [TBL] [Abstract][Full Text] [Related]
5. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats. Gong L; Kostrzewa RM; Kalbfleisch JH Peptides; 1993; 14(6):1159-64. PubMed ID: 7907787 [TBL] [Abstract][Full Text] [Related]
6. Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. Gong L; Kostrzewa RM; Fuller RW; Perry KW J Pharmacol Exp Ther; 1992 Jun; 261(3):1000-7. PubMed ID: 1602367 [TBL] [Abstract][Full Text] [Related]
7. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Plech A; Brus R; Kalbfleisch JH; Kostrzewa RM Psychopharmacology (Berl); 1995 Jun; 119(4):466-73. PubMed ID: 7480527 [TBL] [Abstract][Full Text] [Related]
9. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
10. Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. Gong L; Kostrzewa RM; Brus R; Fuller RW; Perry KW Brain Res Dev Brain Res; 1993 Nov; 76(1):59-65. PubMed ID: 8306431 [TBL] [Abstract][Full Text] [Related]
11. Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA. Kostrzewa RM; Gong L Pharmacol Biochem Behav; 1991 Jul; 39(3):677-82. PubMed ID: 1686103 [TBL] [Abstract][Full Text] [Related]
12. Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Kostrzewa RM; Brus R; Perry KW; Fuller RW Brain Res Dev Brain Res; 1993 Nov; 76(1):87-93. PubMed ID: 8306435 [TBL] [Abstract][Full Text] [Related]
13. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. Brus R; Kostrzewa RM; Perry KW; Fuller RW J Pharmacol Exp Ther; 1994 Jan; 268(1):231-7. PubMed ID: 8301563 [TBL] [Abstract][Full Text] [Related]
15. Dynorphin modulates dopamine D1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats. van de Witte SV; Groenewegen HJ; Drukarch B; Voorn P Neurosci Lett; 2000 Aug; 290(1):37-40. PubMed ID: 10925169 [TBL] [Abstract][Full Text] [Related]
16. Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Gong L; Kostrzewa RM; Perry KW; Fuller RW Brain Res Dev Brain Res; 1993 Dec; 76(2):233-8. PubMed ID: 8149589 [TBL] [Abstract][Full Text] [Related]